[Retracted] Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression

Table 1

Comparison of baseline data (n (%)).

	Conventional group (n = 40)	Experimental group (n = 40)	t or x^2	value
Gender
Male	24	26	0.213	0.644
Female	16	14
Mean age (year)	66.87 ± 5.34	66.93 ± 5.36	−0.05	0.96
Smoking
Yes	27	28	0.058	0.809
No	13	12
TNM staging
IIIA	18	20	0.075	0.785
IIIB	13	12
IV	9	8
Pathological type
Adenocarcinoma	37	38	0.213	0.644
Adenosquamous carcinoma	3	2